Skip to Main Content

Paper Details

First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors.
Clin Cancer Res
29
2020
Author NameAffiliation
Joaquin MateoThe Royal Marsden NHS Foundation Trust
Roberta FerraldeschiAstex Pharmaceuticals
  • 1 - 2

Datasets

Release 1.2